Psychemedics Stock Today
| PMD Stock | USD 2.56 0.02 0.79% |
Performance0 of 100
| Odds Of DistressLess than 11
|
Psychemedics is trading at 2.56 as of the 18th of April 2024, a 0.79 percent up since the beginning of the trading day. The stock's lowest day price was 2.54. Psychemedics has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Psychemedics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 17th of February 1994 | Category Healthcare | Classification Health Care |
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. The company has 5.81 M outstanding shares of which 15.92 K shares are at this time shorted by investors with about 1.25 days to cover. More on Psychemedics
Moving together with Psychemedics Stock
| 0.8 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Psychemedics Stock
| 0.62 | HIMS | Hims Hers Health Financial Report 13th of May 2024 | PairCorr |
| 0.61 | WST | West Pharmaceutical Earnings Call This Week | PairCorr |
| 0.57 | HOLX | Hologic Financial Report 6th of May 2024 | PairCorr |
| 0.51 | ELMD | Electromed | PairCorr |
| 0.5 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
| 0.46 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.42 | RMD | ResMed Inc Earnings Call This Week | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Psychemedics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Psychemedics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Psychemedics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Brian Hullinger | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Psychemedics' liquidity, profitability, solvency, and operating efficiency, Psychemedics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Psychemedics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Psychemedics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Psychemedics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Psychemedics' financial leverage. It provides some insight into what part of Psychemedics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Psychemedics (PMD) is traded on NASDAQ Exchange in USA. It is located in 5220 Spring Valley Road, Dallas, TX, United States, 75254 and employs 116 people. Psychemedics is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 14.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Psychemedics's market, we take the total number of its shares issued and multiply it by Psychemedics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Psychemedics runs under Health Care Providers & Services sector within Health Care industry. The entity has 5.81 M outstanding shares of which 15.92 K shares are at this time shorted by investors with about 1.25 days to cover.
Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Check Psychemedics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Psychemedics is $14.86 Million. Psychemedics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Psychemedics Ownership Details
Psychemedics Stock Price Odds Analysis
What are Psychemedics' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Psychemedics jumping above the current price in 90 days from now is close to 99%. The Psychemedics probability density function shows the probability of Psychemedics stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Psychemedics has a beta of 0.6701 indicating as returns on the market go up, Psychemedics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Psychemedics will be expected to be much smaller as well. Additionally, psychemedics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Psychemedics to move above the current price in 90 days from now is close to 99 (This Psychemedics probability density function shows the probability of Psychemedics Stock to fall within a particular range of prices over 90 days) .
Psychemedics Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Psychemedics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Psychemedics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Psychemedics' value.| Instituion | Recorded On | Shares | |
| Santa Monica Partners Lp | 2023-12-31 | 20 K | |
| Northern Trust Corp | 2023-12-31 | 15.3 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 3.5 K | |
| Tower Research Capital Llc | 2023-12-31 | 2.3 K | |
| Your Advocates Ltd., Llp | 2023-12-31 | 1.4 K | |
| Fmr Inc | 2023-12-31 | 625 | |
| Capital Advisors, Ltd. Llc | 2023-09-30 | 60.0 | |
| Wells Fargo & Co | 2023-12-31 | 37.0 | |
| Caldwell Sutter Capital Inc | 2023-12-31 | 30.0 | |
| 22nw, Lp | 2023-12-31 | 274.4 K | |
| Renaissance Technologies Corp | 2023-12-31 | 265.6 K |
Psychemedics Historical Income Statement
Psychemedics Income Statement is one of the three primary financial statements used for reporting Psychemedics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Psychemedics revenue and expense. Psychemedics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Psychemedics' Gross Profit is projected to decrease significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 1.2 M, whereas Total Revenue is forecasted to decline to about 20.8 M. View More FundamentalsPsychemedics Stock Against Markets
Picking the right benchmark for Psychemedics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Psychemedics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Psychemedics is critical whether you are bullish or bearish towards Psychemedics at a given time. Please also check how Psychemedics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Psychemedics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Psychemedics Corporate Directors
Psychemedics corporate directors refer to members of a Psychemedics board of directors. The board of directors generally takes responsibility for the Psychemedics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Psychemedics' board members must vote for the resolution. The Psychemedics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Clinton Allen | Independent Director | Profile | |
| Harry Connick | Independent Director | Profile | |
| Fred Weinert | Independent Director | Profile | |
| Walter Tomenson | Independent Director | Profile |
How to buy Psychemedics Stock?
Before investing in Psychemedics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Psychemedics. To buy Psychemedics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Psychemedics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Psychemedics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Psychemedics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Psychemedics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Psychemedics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Psychemedics Stock please use our How to Invest in Psychemedics guide.
Already Invested in Psychemedics?
The danger of trading Psychemedics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Psychemedics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Psychemedics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Psychemedics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Psychemedics is a strong investment it is important to analyze Psychemedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psychemedics' future performance. For an informed investment choice regarding Psychemedics Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psychemedics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Psychemedics Stock analysis
When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 0.07 | Earnings Share (0.72) | Revenue Per Share 3.85 | Quarterly Revenue Growth (0.12) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.